13FAVALYN PHARMACEUTICALS INC (AVLN)
4 tracked managers currently hold AVLN on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | Q2 2026 | NEW | $31.6M | 0.0 % | — | 959,098 | NEW |
| D. E. Shaw & Co., Inc. | Q2 2026 | NEW | $757.2K | 0.0 % | — | 23,000 | NEW |
| SOROS FUND MANAGEMENT LLC | Q2 2026 | NEW | $329.2K | 0.0 % | — | 10,000 | NEW |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | NEW | $219.7K | 0.0 % | — | 6,675 | NEW |